Bruderman Asset Management, LLC Merck & Co., Inc. Transaction History

Bruderman Asset Management, LLC

$55.7 Million
Q2 2022

A detailed history of Bruderman Asset Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bruderman Asset Management, LLC holds 12,415 shares of MRK stock, worth $1.41 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares

12,415

Previous 13,121 5.38%

Holding current value

$1.41 Million

Previous $1.08 Million 5.2%

% of portfolio

2.03%

Previous 1.62%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $58,943 - $66,815	-706 Reduced 5.38%	12,415 $1.13 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $751,639 - $842,540	-10,225 Reduced 43.8%	13,121 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $2.78 Million - $3.49 Million	-38,519 Reduced 62.26%	23,346 $1.79 Million
Q3 2021 Oct 13, 2021	BUY	$71.68 - $78.83 $47,022 - $51,712	656 Added 1.07%	61,865 $4.65 Million
Q2 2021 Jul 14, 2021	BUY	$70.31 - $77.77 $17,788 - $19,675	253 Added 0.42%	61,209 $4.76 Million
Q1 2021 Apr 23, 2021	BUY	$68.86 - $81.11 $77,949 - $91,816	1,132 Added 1.89%	60,956 $4.7 Million
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $198,659 - $220,471	2,768 Added 4.85%	59,824 $4.89 Million
Q3 2020 Oct 14, 2020	SELL	$73.18 - $82.95 $4.03 Million - $4.57 Million	-55,108 Reduced 49.13%	57,056 $4.73 Million
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $128,446 - $146,157	1,824 Added 1.65%	112,164 $8.76 Million
Q1 2020 Apr 28, 2020	BUY	$63.36 - $87.82 $86,423 - $119,786	1,364 Added 1.25%	110,340 $8.14 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $517,070 - $583,454	-6,665 Reduced 5.76%	108,976 $10 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $903,678 - $985,042	-11,878 Reduced 9.31%	115,641 $9.67 Million
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $65,859 - $76,939	-943 Reduced 0.73%	127,519 $10.7 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $1.86 Million - $2.12 Million	-26,668 Reduced 17.19%	128,462 $10.7 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $343,162 - $398,234	-5,260 Reduced 3.28%	155,130 $11.9 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $4.96 Million - $5.84 Million	86,031 Added 115.7%	160,390 $11.4 Million
Q2 2018 Aug 15, 2018	BUY	$50.83 - $59.72 $1.67 Million - $1.96 Million	32,868 Added 79.22%	74,359 $4.51 Million
Q1 2018 May 10, 2018	BUY	$50.96 - $59.23 $1.34 Million - $1.55 Million	26,209 Added 171.5%	41,491 $2.26 Million
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $47,180 - $56,338	-914 Reduced 5.64%	15,282 $860,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $950,219 - $1.02 Million	16,196	16,196 $1.04 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruderman Asset Management, LLC with notifications on news.

Account

Bruderman Asset Management, LLC Merck & Co., Inc. Transaction History